P1032 (10137): Phase II Study of the Pharmacokinetics of Nevirapine and the Incidence of Nevirapine-Resistance Mutations in HIV-Infected Women Receiving a Single Intrapartum Dose of Nevirapine Alone or in Combination with ZDV/ddI or ZDV/ddI/LPV/r

Study Status Study Restriction

Concluded

US & Non-US

Sites where the study was implemented:

CRS ID Site Name City Country
No records returned.

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.